Clinical Trial Results:
A randomised, double-blind, placebo-controlled, multi-centre, 6-way cross-over, single-dose Phase IIa study to investigate the local and systemic effects of 3 different doses of inhaled AZD2115 compared with active comparators, in patients with chronic obstructive pulmonary disease (COPD)
Summary
|
|
EudraCT number |
2011-004641-41 |
Trial protocol |
SE PL |
Global completion date |
23 Oct 2012
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
27 Oct 2016
|
First version publication date |
27 Oct 2016
|
Other versions |
|
Summary report(s) |
D3060C00003_CSR |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.